Bionano Genomics Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
56.9%projected annual EPS growth
Analyst Coverage
2analysts covering
FY Revenue (est.)
$32.1Mnext fiscal year
FY EPS (est.)
-$2.71next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Financial Results Call | 12 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Nanochannel Array Flow Cells Sold Quarterly8.2K
GAAP Gross Margin Quarterly49.0%
Total Revenue Annually6.7MTarget: 30000000 to 33000000
Watch Items
- Going Concern and Liquidity RunwayTrigger: Cash and cash equivalents falling below $3.0 million without new financingAction: Evaluate capital raising options, strategic partnerships, or further operational restructuring to extend runway.
- Leadership Transition and CEO SearchTrigger: Appointment of a permanent Chief Executive OfficerAction: Assess the strategic direction and operational focus of the new leadership team.
Research as of 20 Jun 2026